NASDAQ : BMGL
Basel Medical Group Ltd — Key statistics
Healthcare · Medical Care Facilities · Singapore
Last price 4.75 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 7.52M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 7.97M |
| Enterprise Value | 15.00M |
Dates
| Measure | Value |
|---|
| Earnings Date | Jun 26, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 1.58M |
| Shares Outstanding | 1.58M |
| Shares Change (YoY) | +23.41% |
| Shares Change (QoQ) | -11.89% |
| Owned by Insiders (%) | 13.50% |
| Owned by Institutions (%) | 0.07% |
| Float | 518,049 |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.48 |
| Forward PS | n/a |
| PB Ratio | 2.06 |
| P/TBV Ratio | 2.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.90 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.23 |
| Quick Ratio | 1.10 |
| Debt / Equity | 2.12 |
| Debt / EBITDA | 3.10 |
| Debt / FCF | n/a |
| Interest Coverage | -1.72 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -28.66% |
| Return on Assets (ROA) | -2.71% |
| Return on Invested Capital (ROIC) | -54.56% |
| Return on Capital Employed (ROCE) | -9.97% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $202,728 |
| Profits Per Employee | -$7,049 |
| Employee Count | 82 |
| Asset Turnover | 1.18 |
| Inventory Turnover | 36.59 |
Taxes
| Measure | Value |
|---|
| Income Tax | 138,755 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | -72.55% |
| 50-Day Moving Average | 4.40 |
| 200-Day Moving Average | 6.57 |
| Relative Strength Index (RSI) | 66.65 |
| Average Volume (20 Days) | 1,054,095 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 12,972 |
| Short Previous Month | 11,310 |
| Short % of Shares Out | 0.82% |
| Short % of Float | 2.50% |
| Short Ratio (days to cover) | 0.05 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 16.62M |
| Gross Profit | 6.44M |
| Operating Income | -610,857 |
| Pretax Income | -965,801 |
| Net Income | -578,008 |
| EBITDA | -339,878 |
| EBIT | -610,857 |
| Loss Per Share | -$0.60 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 409,467 |
| Total Debt | 7.43M |
| Net Cash | -7.02M |
| Net Cash Per Share | -$4.44 |
| Equity (Book Value) | 3.51M |
| Book Value Per Share | 2.44 |
| Working Capital | 1.75M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -1.48M |
| Capital Expenditures | -8.60M |
| Depreciation & Amortization | 217,981 |
| Net Borrowing | 5.15M |
| Free Cash Flow | -10.09M |
| FCF Per Share | -$6.37 |
Margins
| Measure | Value |
|---|
| Gross Margin | 38.77% |
| Operating Margin | -3.67% |
| Pretax Margin | -5.81% |
| Profit Margin | -3.48% |
| EBITDA Margin | -2.04% |
| EBIT Margin | -3.67% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -23.41% |
| Shareholder Yield | -23.41% |
| Earnings Yield | -11.96% |
| FCF Yield | -126.49% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jun 22, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |